In patients with DM, old age (age ≥ 45 years old) and low serum levels of CPK showed a significant difference between the malignancy group and the nonmalignancy group (p = 0.003 and p = 0.05, respectively). This evidence concerns the gene PIK3C2A and diabetes mellitus.